GW Pharmaceuticals PLC Holding(s) in Company (4823E)
11 May 2013 - 1:28AM
UK Regulatory
TIDMGWP
RNS Number : 4823E
GW Pharmaceuticals PLC
10 May 2013
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
--------------------------------------------------------------------------------------
1. Identity of the issuer or the underlying GW Pharmaceuticals PLC
issuer
of existing shares to which voting rights
are
attached: (ii)
-------------------------------------------------- ----------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
--------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
----------------------------------------------------------------------------- -------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
----------------------------------------------------------------------------- -------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
----------------------------------------------------------------------------- -------
An event changing the breakdown of voting rights x
----------------------------------------------------------------------------- -------
Other (please Change of custodian
specify):
------------------- -------------------------------------------------------- -------
3. Full name of person(s) subject Farallon Capital Management L.L.C
to the
notification obligation: (iii)
-------------------------------------------- ----------------------------------------
4. Full name of shareholder(s) N/A
(if different from 3.):(iv)
-------------------------------------------- ----------------------------------------
5. Date of the transaction and date 9 May 2013
on
which the threshold is crossed
or
reached: (v)
-------------------------------------------- ----------------------------------------
6. Date on which issuer notified: 9 May 2013
-------------------------------------------- ----------------------------------------
7. Threshold(s) that is/are crossed
or
reached: (vi, vii) 5%
-------------------------------------------- ----------------------------------------
8. Notified details:
------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if
possible
using
the ISIN
CODE
----------- ---------------------------------------- -----------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of rights (x)
Shares Voting shares
Rights
----------- ---------------- ---------------------- --------- ----------------------- -----------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
----------- --- ---- ----- ------ ----- ---- --------- ------------ --------- ------------- --------------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
---------------------- ---------------- ---------------------------- -------------------------- --------------------
American depository Below 5% Below 5%
US36197T1034
---------------------- ---------------- ---------------------------- -------------------------- --------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date (xvii) Conversion rights instrument (xix, xx)
instrument period refers to
(xviii)
---------------- -------------- ------------- --------------- --------------------------- -------------------------
Nominal Delta
---------------- -------------- ------------- --------------- --------------------------- ------------ -----------
Total (A+B+C)
------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
-------------------------------------------------------------- --------------------------------------------------------
Below 5% Below 5%
-------------------------------------------------------------- --------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
----------------------------------------------------------------------------------------
Proxy Voting:
----------------------------------------------------------------------------------------
10. Name of the proxy holder:
----------------------------------------------------- ---------------------------------
11. Number of voting rights proxy holder will
cease
to hold:
----------------------------------------------------- ---------------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
----------------------------------------------------- ---------------------------------
The underlying shares to which the
13. Additional information: ADRs described in section 8. B above
relate have now been admitted to trading
on the Alternative Investment Market
and the issuer has made a total voting
rights announcement reflecting the
newly issued shares. Therefore, while
the ADS position has not changed,
the percentage of the issuer's total
voting rights represented by that
position has, as a result of the admission
of the new shares to trading, dropped
below 5%.
---------------------------------------- ----------------------------------------------
14. Contact name: Elizabeth Wallace
---------------------------------------- ----------------------------------------------
15. Contact telephone number: + 1 415 421 2132
---------------------------------------- ----------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEASSEFASDEFF
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles